15th February 2024

A group of researchers identified 600 patients who had received 5-FU and 500 patients who had received capecitabine as chemotherapy agents.

A group of researchers identified 600 patients who had received 5-FU and 500 patients who had received capecitabine as chemotherapy agents. They have followed up with both patient groups to identify patients who developed palmar-plantar erythrodysesthesia (PPE).

Which statistical test is most appropriate to identify significant differences between the onset of PPE and both chemotherapy agents?